{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Absence of large scale testing for COVID-19\",\"Impact\":\"Inability to accurately identify the actual number of infected patients\",\"Mitigation\":\"Increase access to large scale testing facilities and implement widespread testing programs\",\"Technologies\":\"Testing kits, laboratory equipment, and automation technology for testing facilities\",\"People\":\"General population, healthcare workers, and public health authorities\",\"Owner\":\"Government health departments and public health organizations\"},{\"Description\":\"Inadequate contact tracing\",\"Impact\":\"Difficulty in identifying and isolating individuals with a history of exposure to infected persons\",\"Mitigation\":\"Implement comprehensive contact tracing programs, utilize digital contact tracing apps, and increase resources for contact tracing teams\",\"Technologies\":\"Contact tracing applications, data analytics, and digital tools for monitoring and tracking\",\"People\":\"Public health authorities, contact tracing teams, and individuals with a history of exposure\",\"Owner\":\"Health departments and technology companies\"},{\"Description\":\"Inadequate access to accurate COVID-19 tests\",\"Impact\":\"Inability to detect and diagnose SARS-CoV-2 infection in individuals, leading to uncontrolled transmission\",\"Mitigation\":\"Develop and deploy accurate and reliable molecular tests at scale, establish testing facilities in strategic locations, and ensure accessibility to testing for the population\",\"Technologies\":\"Nucleic Acid Amplification Tests (NAAT), sample collection devices, and laboratory testing equipment\",\"People\":\"General population, healthcare workers, and individuals seeking testing\",\"Owner\":\"Healthcare providers, government health agencies, and public health organizations\"}]}"}}